by Ludwig Maximilian University of Munich Infrared molecular fingerprinting workflow and clinical study design. (a) Cohorts of therapy-naïve, lung, breast, prostate, and bladder cancer patients (cases), and organ-specific symptomatic references as well as non-symptomatic reference individuals were recruited at three different clinical sites – in total, 1927 individuals. (b) Blood samples from all individuals were...
